Back to results
CompletedPhase 2Phase 3

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

NCT04429503

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Regeneron Study Site

Phoenix, Arizona, United States

+137 additional locations

View on ClinicalTrials.gov
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease — TrialFind